F

FERRERAS A.

Last name: FERRERAS A.

2019 (v1)

Publication

Metadata-only

Timolol 0.1% in Glaucomatous Patients: Efficacy, Tolerance, and Quality of Life

Negri L. Ferreras A. Iester M.

Glaucoma is a progressive, chronic optic neuropathy characterized by a typical visual field defects. Four main classes of topical medication are actually available on the market: beta-blockers, prostaglandins, alpha2-agonists, and topical carbonic anhydrase inhibitor to treat intraocular pressure (IOP). The aim of this review is to outline the...

Uploaded on: April 14, 2023
2015 (v1)

Publication

Metadata-only

Glaucoma structure progression by using Heidelberg Retina Tomograph (HRT).

IESTER, MICHELE TRAVERSO, CARLO Gil Aribas L

No description

Uploaded on: April 14, 2023
2019 (v1)

Publication

Metadata-only

Managing Side Effects on Ocular Surface Caused by Glaucoma Eye Drops

Ferreras A. Figus M. Fogagnolo P.

No description

Uploaded on: April 14, 2023
2017 (v1)

Publication

Metadata-only

Artificial tear substitutes and ocular surface in glaucoma patients with chronic treatment.

Iester M Figus M Fogagnolo P

No description

Uploaded on: April 14, 2023
2018 (v1)

Publication

Metadata-only

Ocular surface in patients with chronic glaucoma treatment and differentartificial tear substitutes.

Iester M Fogagnolo P Oddone F

No description

Uploaded on: April 14, 2023